The Current Ratio as of November 2024 (TTM) for EyePoint Pharmaceuticals, Inc. (EYPT) is 5.50

According to EyePoint Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.50. This represents a change of 5.94% compared to the average of 5.19 of the last 4 quarters.

EyePoint Pharmaceuticals, Inc. (EYPT) Historical Current Ratio (quarterly & annually)

How has EYPT Current Ratio performed in the past?

The mean historical Current Ratio of EyePoint Pharmaceuticals, Inc. over the last ten years is 5.74. The current 5.50 Current Ratio has changed 9.49% with respect to the historical average. Over the past ten years (40 quarters), EYPT's Current Ratio was at its highest in in the December 2014 quarter at 16.43. The Current Ratio was at its lowest in in the March 2018 quarter at 0.83.

EyePoint Pharmaceuticals, Inc. (EYPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of EyePoint Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

EyePoint Pharmaceuticals, Inc. (EYPT) Average Current Ratio

How has EYPT Current Ratio performed in the past?

The current Current Ratio of EyePoint Pharmaceuticals, Inc. (EYPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

EyePoint Pharmaceuticals, Inc. (EYPT) Current Ratio vs. Peers

How is EYPT’s Current Ratio compared to its peers?

EyePoint Pharmaceuticals, Inc.’s Current Ratio is less than Ocuphire Pharma, Inc. (10.68), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Protalix BioTherapeutics, Inc. (1.98), greater than SELLAS Life Sciences Group, Inc. (2.26), less than Alpha Tau Medical Ltd. (10.99), greater than HCW Biologics Inc. (0.07), greater than Innate Pharma S.A. (2.92), greater than Orchestra BioMed Holdings, Inc. (4.23), less than Chimerix, Inc. (6.33), less than Day One Biopharmaceuticals, Inc. (14.62), greater than X4 Pharmaceuticals, Inc. (4.89), less than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), greater than ALX Oncology Holdings Inc. (4.82), less than Cabaletta Bio, Inc. (8.11), greater than Viracta Therapeutics, Inc. (0.76), greater than Biomea Fusion, Inc. (3.39), less than Acumen Pharmaceuticals, Inc. (10.43), greater than HOOKIPA Pharma Inc. (3.26),

Build a custom stock screener for EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EyePoint Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EyePoint Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.